Nature, Published online: 04 February 2026; doi:10.1038/s41586-025-10036-8

ATF6α activation in human and preclinical models of hepatocellular carcinoma is significantly associated with an aggressive tumour phenotype characterized by reduced survival, glycolytic reprogramming and local immunosuppression.

From Nature via this RSS feed